Efficacy and Safety of Antiviral Therapy With Peg-interferon for Chronic Hepatitis B Complicated With Nonalcoholic Fatty Liver Disease（OCEAN PROJECT）

NCT06368882 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease
Chronic Hepatitis b

Interventions

DRUG: Peg-Interferon α

Sponsor

First Affiliated Hospital of Wenzhou Medical University